熱門資訊> 正文

AC Immune首席执行官Andrea Pfeifer将在23年后退休

2026-05-12 20:15

AC Immune (ACIU) on Tuesday said co-founder and CEO Andrea Pfeifer will retire at the company’s upcoming annual general meeting after leading the neurodegenerative disease drug developer for 23 years.
Board Chair Martin Zügel will take over as interim CEO while the company searches for a permanent successor.
Pfeifer will remain involved as an advisor, honorary chair of the board, and co-chair of the scientific advisory board.

More on AC Immune

AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts
AC Immune rises after amending licensing deal with Lilly
AC Immune says partner J&J pauses enrollment in mid-stage trial for Alzheimer’s drug
Seeking Alpha’s Quant Rating on AC Immune
Historical earnings data for AC Immune

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。